| Primary |
| Contraception |
33.3% |
| Hormone Replacement Therapy |
17.5% |
| Drug Use For Unknown Indication |
9.6% |
| Menorrhagia |
7.0% |
| Menopausal Symptoms |
4.4% |
| Adverse Event |
2.6% |
| Amenorrhoea |
2.6% |
| Injectable Contraception |
2.6% |
| Menopause |
2.6% |
| Uterine Disorder |
2.6% |
| Endometrial Hyperplasia |
1.8% |
| Menstrual Cycle Management |
1.8% |
| Menstrual Discomfort |
1.8% |
| Off Label Use |
1.8% |
| Polycystic Ovaries |
1.8% |
| Sinusitis |
1.8% |
| Vaginitis Bacterial |
1.8% |
| Acne |
0.9% |
| Drug Therapy |
0.9% |
| Dysmenorrhoea |
0.9% |
|
| Breast Cancer Female |
48.3% |
| Breast Cancer |
5.2% |
| Unintended Pregnancy |
5.2% |
| Pregnancy With Injectable Contraceptive |
4.3% |
| Progesterone Receptor Assay Positive |
3.4% |
| Weight Decreased |
3.4% |
| Weight Increased |
3.4% |
| Device Failure |
2.6% |
| Haemorrhage |
2.6% |
| Pharmaceutical Product Complaint |
2.6% |
| Pulmonary Embolism |
2.6% |
| Vaginal Haemorrhage |
2.6% |
| Alopecia |
1.7% |
| Anaphylactic Reaction |
1.7% |
| Breast Cancer Metastatic |
1.7% |
| Kidney Infection |
1.7% |
| Maternal Exposure During Pregnancy |
1.7% |
| Metrorrhagia |
1.7% |
| Ovarian Cancer |
1.7% |
| Paraesthesia |
1.7% |
|
| Secondary |
| Hormone Replacement Therapy |
73.8% |
| Menopausal Symptoms |
10.6% |
| Menopause |
6.8% |
| Oestrogen Replacement Therapy |
1.3% |
| Hypertension |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Product Used For Unknown Indication |
0.6% |
| Hot Flush |
0.6% |
| Osteoporosis |
0.5% |
| Depression |
0.4% |
| Asthma |
0.4% |
| Menorrhagia |
0.4% |
| Osteoporosis Prophylaxis |
0.4% |
| Anxiety |
0.3% |
| Prophylaxis |
0.3% |
| Emphysema |
0.3% |
| Mood Swings |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Thyroid Disorder |
0.3% |
| Hormone Therapy |
0.3% |
|
| Breast Cancer |
60.2% |
| Breast Cancer Female |
20.6% |
| Breast Cancer Metastatic |
6.4% |
| Breast Cancer In Situ |
2.3% |
| Progesterone Receptor Assay Positive |
2.3% |
| Ovarian Cancer |
1.4% |
| Breast Cancer Recurrent |
0.9% |
| Contralateral Breast Cancer |
0.7% |
| Thrombosis |
0.7% |
| Deep Vein Thrombosis |
0.6% |
| Cerebrovascular Accident |
0.5% |
| Uterine Leiomyoma |
0.5% |
| Ovarian Cancer Metastatic |
0.5% |
| Invasive Ductal Breast Carcinoma |
0.4% |
| Pulmonary Embolism |
0.4% |
| Weight Increased |
0.4% |
| Pain |
0.4% |
| Staphylococcal Infection |
0.4% |
| Myocardial Infarction |
0.3% |
| Product Counterfeit |
0.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.1% |
| Drug Use For Unknown Indication |
17.7% |
| Pain |
6.7% |
| Contraception |
5.1% |
| Hypertension |
4.4% |
| Depression |
4.3% |
| Hormone Replacement Therapy |
3.8% |
| Anxiety |
2.9% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Rheumatoid Arthritis |
2.7% |
| Diabetes Mellitus |
2.6% |
| Osteoporosis |
2.5% |
| Blood Follicle Stimulating Hormone Decreased |
2.2% |
| Blood Luteinising Hormone Decreased |
2.2% |
| Menopause |
2.2% |
| Acne |
2.1% |
| Premenstrual Syndrome |
2.1% |
| Asthma |
2.0% |
| Bipolar Disorder |
1.9% |
| Hypogonadism Female |
1.8% |
|
| Vomiting |
16.7% |
| Weight Increased |
11.6% |
| Pain |
8.0% |
| Pulmonary Embolism |
6.8% |
| Type 2 Diabetes Mellitus |
6.4% |
| Nausea |
4.8% |
| Weight Decreased |
4.8% |
| Suicidal Ideation |
4.4% |
| Abortion Spontaneous |
3.6% |
| Diarrhoea |
3.6% |
| Injury |
3.6% |
| Swelling |
3.6% |
| Vitreous Floaters |
3.6% |
| Deep Vein Thrombosis |
3.2% |
| Rash |
3.2% |
| Urticaria |
2.8% |
| Drug Ineffective |
2.4% |
| Emotional Distress |
2.4% |
| Menorrhagia |
2.4% |
| Thrombophlebitis Superficial |
2.4% |
|
